Pediatric anesthesia & critical care

Improving perioperative acetaminophen administration for safer and cost‐effective multimodal analgesia in pediatric surgery: A QI initiative

Paediatr AnaesthPublished Quality improvement study

Authors' conclusion

We successfully achieved and sustained our goals of improving acetaminophen use for our surgical patients without worsening pain scores or worsening use of intravenous opioids.

Study context

Population
Pediatric surgical patients
Comparison
Before vs after QI interventions
Outcome
Percentage of surgical patients receiving any form (oral or IV) of perioperative acetaminophen
Follow-up
24 months
Methodological detailsmultidisciplinary team, model for improvement, Monthly data collected using an automated electronic medical record (EMR) report
  • Multidisciplinary team
  • Model for improvement
  • Monthly data collected using an automated EMR report

Main finding

As reported in the abstract

Perioperative acetaminophen use (oral or IV), % of surgical patients
  • Perioperative acetaminophen use increased from a baseline of 39.5% to 63% by the end of 24 months, surpassing the 50% goal
  • Pre-post QI comparison, no concurrent control

Further findings

Perioperative acetaminophen use, early · 4 months

Acetaminophen use increased from 39.5% to 70% within four months

Oral acetaminophen use

Oral acetaminophen use increased from a baseline of 10% to 78%

Average maximum PACU pain score

Average maximum PACU pain score improved from 5.4 to 5.2

Patients receiving rescue opioids, %

Patients receiving rescue opioids decreased from 15.4 to 13.1

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Improving perioperative acetaminophen administration for safer and cost‐effective multimodal analgesia in pediatric surgery: A QI initiative. Paediatr Anaesth. Published 5 April 2024. doi:10.1111/pan.14893

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.